EE200300500A - Merkaptoatsetüülamiidi derivaadid, nende valmistamismeetod, farmatseutiline kompositsioon ja selle valmistamismeetod - Google Patents

Merkaptoatsetüülamiidi derivaadid, nende valmistamismeetod, farmatseutiline kompositsioon ja selle valmistamismeetod

Info

Publication number
EE200300500A
EE200300500A EEP200300500A EEP200300500A EE200300500A EE 200300500 A EE200300500 A EE 200300500A EE P200300500 A EEP200300500 A EE P200300500A EE P200300500 A EEP200300500 A EE P200300500A EE 200300500 A EE200300500 A EE 200300500A
Authority
EE
Estonia
Prior art keywords
preparation
pharmaceutical composition
compounds
mercaptoacetylamide derivatives
disclosed
Prior art date
Application number
EEP200300500A
Other languages
English (en)
Inventor
A. Flynn Gary
Mehdi Shujaath
Roger Koehl Jack
Ann Anderson Barbara
Gerken Manfred
Jablonka Bernd
Kleemann Heinz-Werner
Linz Wolfgang
Seiz Werner
Seuring Bernhard
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0119305.1A external-priority patent/GB0119305D0/en
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200300500A publication Critical patent/EE200300500A/et
Publication of EE05272B1 publication Critical patent/EE05272B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
EEP200300500A 2001-04-12 2002-04-03 Merkaptoatsetlamiidi derivaadid, nende valmistamismeetod ja kasutamine EE05272B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28330501P 2001-04-12 2001-04-12
GBGB0119305.1A GB0119305D0 (en) 2001-04-12 2001-08-08 Mercaptoacetylamide derivatives,a process for their preparation and their use
PCT/EP2002/003668 WO2002083671A1 (en) 2001-04-12 2002-04-03 Mercaptoacetylamide derivatives, a process for their preparation and their use

Publications (2)

Publication Number Publication Date
EE200300500A true EE200300500A (et) 2003-12-15
EE05272B1 EE05272B1 (et) 2010-02-15

Family

ID=26246410

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300500A EE05272B1 (et) 2001-04-12 2002-04-03 Merkaptoatsetlamiidi derivaadid, nende valmistamismeetod ja kasutamine

Country Status (27)

Country Link
EP (1) EP1381605B1 (et)
JP (1) JP4392167B2 (et)
CN (1) CN1245404C (et)
AT (1) ATE286898T1 (et)
AU (1) AU2002304804B2 (et)
BG (1) BG66387B1 (et)
BR (1) BR0208889A (et)
CA (1) CA2443488C (et)
CZ (1) CZ299708B6 (et)
DE (1) DE60202602T2 (et)
EE (1) EE05272B1 (et)
ES (1) ES2232752T3 (et)
HK (1) HK1061690A1 (et)
HR (1) HRP20030823B1 (et)
HU (1) HU229612B1 (et)
IL (1) IL158289A0 (et)
MA (1) MA26098A1 (et)
MX (1) MXPA03008613A (et)
NO (1) NO325655B1 (et)
NZ (1) NZ528825A (et)
OA (1) OA12502A (et)
PL (1) PL209338B1 (et)
PT (1) PT1381605E (et)
RU (1) RU2286346C2 (et)
SI (1) SI1381605T1 (et)
SK (1) SK287616B6 (et)
WO (1) WO2002083671A1 (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10229180A1 (de) 2002-06-28 2004-01-29 Aventis Pharma Deutschland Gmbh Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen
US8993631B2 (en) 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
US5430145A (en) * 1990-10-18 1995-07-04 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
DE69220744T2 (de) * 1991-09-27 1997-11-13 Merrell Pharma Inc 2-Substituierte Indan-2-Mercaptoacetylamid-Verbindungen mit Enkephalinase und ACE-Hemmwirkung
WO1994028901A1 (fr) * 1993-06-11 1994-12-22 Eisai Co., Ltd. Derive aminoacide

Also Published As

Publication number Publication date
CZ20032722A3 (cs) 2004-01-14
SI1381605T1 (en) 2005-06-30
PL209338B1 (pl) 2011-08-31
IL158289A0 (en) 2004-05-12
RU2286346C2 (ru) 2006-10-27
ATE286898T1 (de) 2005-01-15
EE05272B1 (et) 2010-02-15
HUP0303482A3 (en) 2012-12-28
OA12502A (fr) 2006-05-29
CN1245404C (zh) 2006-03-15
HRP20030823A2 (en) 2005-08-31
RU2003132875A (ru) 2005-03-20
NZ528825A (en) 2005-04-29
NO325655B1 (no) 2008-06-30
BG66387B1 (bg) 2013-11-29
SK12552003A3 (sk) 2004-03-02
PT1381605E (pt) 2005-03-31
HRP20030823B1 (en) 2011-10-31
MA26098A1 (fr) 2004-04-01
EP1381605A1 (en) 2004-01-21
DE60202602T2 (de) 2006-03-23
EP1381605B1 (en) 2005-01-12
CZ299708B6 (cs) 2008-10-29
SK287616B6 (sk) 2011-04-05
BR0208889A (pt) 2004-06-29
JP2004525966A (ja) 2004-08-26
NO20034412L (no) 2003-10-02
AU2002304804B2 (en) 2007-05-10
PL363034A1 (en) 2004-11-15
HU229612B1 (en) 2014-03-28
HK1061690A1 (en) 2004-09-30
DE60202602D1 (de) 2005-02-17
HUP0303482A2 (hu) 2004-01-28
NO20034412D0 (no) 2003-10-02
MXPA03008613A (es) 2003-12-08
CA2443488A1 (en) 2002-10-24
ES2232752T3 (es) 2005-06-01
CA2443488C (en) 2011-05-31
JP4392167B2 (ja) 2009-12-24
CN1501926A (zh) 2004-06-02
BG108203A (bg) 2004-12-30
WO2002083671A1 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
TNSN03083A1 (en) Mercaptoacetylamide derivatives, a process for their preparation and their use
NO20063479L (no) Fosfonater, monofosfonamidater og bis-fosfonamidater for behandling av virussykdommer
CY1115526T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει πιμοβενδανη
MXPA04004741A (es) Derivados de tiazol que tienen actividad antagonista, agonista o agonista parcial alcanabinoide1.
MY142109A (en) Pyrimidine derivatives for the treatment of abnormal cell growth
MY146669A (en) Pyrazole derivatives for treating hiv
NO20065075L (no) Ikke-nukleosidbaserte revers-transkriptase-inhibitorer.
CL2003002042A1 (es) Compuestos derivados de 3,9-diazabiciclo[3.3.1]noneno; composicion farmaceutica; y uso del compuesto como inhibidor de renina (ras), para tratar hipertension, insuficiencia cardiaca congestiva, hipertension pulmonar, insuficiencia renal, ateroscleros
NO20041379L (no) Enzymatiske prosesser for fremstilling av 4-substituerte 3-hydroksysmorsyrederivater
EP1831239B8 (en) A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process
MY127495A (en) Dipeptide derivatives
WO2003082857A3 (en) Lansoprazole polymorphs and processes for preparation thereof
NO20060417L (no) Fremgangsmate til fremstilling av 1-okten fra krakk-C4
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
WO2003006670A3 (en) 2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
DE60310767D1 (de) PYRAZOL-3,4-d-PYRIMIDINDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON H.PYLORI-INFEKTIONEN
WO2004012663A3 (en) Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme
WO2004050663A3 (en) An improved process for the preparation of cefuroxime sodium
AU2003263498A1 (en) Pyrazole derivatives
EE200300500A (et) Merkaptoatsetüülamiidi derivaadid, nende valmistamismeetod, farmatseutiline kompositsioon ja selle valmistamismeetod
WO2005100322A8 (en) Sulphur-linked imidazole compounds for the treament of hiv
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
WO2003028645A3 (en) Novel compositions of carvedilol
WO2002010124A3 (en) Salt forms of an hiv protease inhibitor
AU2002326391A1 (en) Carvedilol polymorph

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20160403